Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19
COVID-19로 입원한 미국 재향 군인의 생존 및 입원 기간과 렘데시비르 치료의 연관성
Research
[키워드] 30-Day mortality
95% CI
adjusted
adjusted hazard ratio
Admission
Adult patients
age
Analysis
association
clinical trial
Cohort
cohort study
competing
Control
control patient
controls
COVID-19
Cox proportional hazard
Cox proportional hazards regression
death
Dexamethasone
Effect
exposure
Final
finding
health administration
hospital
hospital discharge
Hospital stay
Hospitalization
Hospitalized
hospitals
identify
Importance
improvement
Improvements
individuals
initial
initiated
intensive care
intensive care unit
interquartile range
laboratory-confirmed
Laboratory-confirmed COVID-19
Length
less
log rank
matched control
matched controls
measure
Measures
mechanical ventilation
median time
men
objective
outcome
participant
Patient
people with COVID-19
Point
Propensity score
propensity score matching
randomized clinical trials
receiving
recipient
Relevance
Remdesivir
Result
retrospective cohort study
routine
routine care
setting
Sex
significant increase
survival
therapy
time
Treatment
treatment initiation
used data
veteran
was used
were assessed
with COVID-19
[DOI] 10.1001/jamanetworkopen.2021.14741 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2021.14741 PMC 바로가기 [Article Type] Research